Avantor

Avantor® to Host Third Quarter 2022 Earnings Call on Friday, October 28, 2022

Retrieved on: 
Thursday, September 29, 2022
Avantor, Research, Fortune 500, LinkedIn, Laboratory, Health, Webcast, Twitter, NYSE, Science, Facebook

To hear a live audio webcast of the call, visit the " Events & Presentations " page of Avantor's website, www.avantorsciences.com , under the "Investors" section.

Key Points: 
  • To hear a live audio webcast of the call, visit the " Events & Presentations " page of Avantor's website, www.avantorsciences.com , under the "Investors" section.
  • A replay of the webcast and related presentation materials will be available for 30 days.
  • Avantor, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.
  • Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve.

Parallaxes Capital Management Highlights the Previously Terminated TRA of a Leading Supplier of Research Laboratory Products

Retrieved on: 
Wednesday, September 28, 2022
Avantor, IPO, Parallax, Inc., Company, Awareness, TRA, Solution, Tras, VWR, Ecosystem, Security (finance)

In the vein of creating greater visibility into the TRA ecosystem, Parallaxes is pleased to share a notable development in the market as VWR Corporation ("VWR" or "the Company") previously terminated its TRA.

Key Points: 
  • In the vein of creating greater visibility into the TRA ecosystem, Parallaxes is pleased to share a notable development in the market as VWR Corporation ("VWR" or "the Company") previously terminated its TRA.
  • Parallaxes Capital Management ("Parallaxes") is the premier investment firm focused exclusively on monetizing Tax Receivable Agreements ("TRAs").
  • Parallaxes offers private equity sponsors, co-investors and management team members solutions to achieve liquidity, diversification and optionality from their TRAs.
  • Parallaxes was founded in 2017 and is comprised of experienced investment professionals from leading private equity and growth equity firms.

XPO Logistics Announces Board of Directors for Planned RXO Spin-Off

Retrieved on: 
Tuesday, September 27, 2022
C. H. Robinson, YouTube, Securities Exchange Act of 1934, Jacobs, Molson Coors Beverage Company, Wilkerson, The Wall Street Journal, Policy, Twitter, NYSE, Hill+Knowlton Strategies, XPO Logistics, Securities Act of 1933, Financial compensation, U.S. Securities and Exchange Commission, Audit committee, LinkedIn, XPO, DuPont, Forward-looking statement, ManpowerGroup, Professional Football Compensation Committee, Instagram, Perception, Steel, Transport, Annamaria, Corporate governance, Honeywell, GLOBE, SEC, LTL, Management, Audit, Cargo, Risk management, U.S. Steel, Facebook, Avantor

GREENWICH, Conn., Sept. 27, 2022 (GLOBE NEWSWIRE) -- XPO Logistics, Inc. (NYSE: XPO) today announced the members of the inaugural board of directors for the planned spin-offof RXO , its tech-enabled brokered transportation platform.

Key Points: 
  • GREENWICH, Conn., Sept. 27, 2022 (GLOBE NEWSWIRE) -- XPO Logistics, Inc. (NYSE: XPO) today announced the members of the inaugural board of directors for the planned spin-offof RXO , its tech-enabled brokered transportation platform.
  • Drew Wilkerson will serve on the board in addition to leading RXO as chief executive officer.
  • Three current XPO directors will join the RXO board as independent directors at the time of the separation, following their planned resignation from the XPO board:
    AnnaMaria DeSalva has been a director of XPO since September 2017, and vice chair since February 2019.
  • XPO Logistics, Inc.(NYSE: XPO) is a leading provider of freight transportation services, primarily less-than-truckload (LTL) and truck brokerage.

Avantor® to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Retrieved on: 
Tuesday, August 30, 2022
CEO, Fortune 500, Avantor, NYSE, Research, Morgan, Health, Science, Laboratory, Conference, Management

A live webcast can be accessed on the investors section of Avantor's website and a replay will be available for approximately 90 days.

Key Points: 
  • A live webcast can be accessed on the investors section of Avantor's website and a replay will be available for approximately 90 days.
  • Avantor, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.
  • Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve.
  • Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries.

Avantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore

Retrieved on: 
Wednesday, August 24, 2022
Science, Fortune 500, The Science of Good and Evil, Research, Conditional sentence, Hope, Topical steroid withdrawal, Health, Laboratory, Education, Organization, Foundation, SATA, Goodness, United States Secretary of Labor, Hospital, Medicine, Avantor

By identifying community needs and addressing them through these grants, the Avantor Foundation is able to contribute to the advancement of healthcare in Singapore and the region.

Key Points: 
  • By identifying community needs and addressing them through these grants, the Avantor Foundation is able to contribute to the advancement of healthcare in Singapore and the region.
  • "By working with SATA CommHealth and HealthServe, we want to connect and help communities, which deserve crucial assistance but are sometimes overlooked.
  • The Avantor Foundation also has provided a grant to HealthServe, a medical NGO that advocates for the needs and wellbeing of vulnerable, low-wage migrant workers in Singapore.
  • Since 2009, the Avantor Foundation has been making a difference in the science community by supporting organizations aligned to its mission.

Ingersoll Rand Announces Appointment of Mark Stevenson and Michael Stubblefield to Board of Directors

Retrieved on: 
Tuesday, August 2, 2022
Manufacturing, Machinery, Engineering, Machine Tools, Metalworking & Metallurgy, Chemicals, Plastics, Acquisition, Knowledge, Chemistry, View, McKinsey & Company, Education, University, Industry, U.S. Securities and Exchange Commission, CEO, NYSE, Texas A&M University–Corpus Christi, SEC, Government, Executive, Henley Business School, Ingersoll Rand, Private Securities Litigation Reform Act, Failure, Retirement, Board, General manager, COVID-19, Multimedia, Mindful Scientific Inc., Chemical engineering, Fortune 500, News, Leadership, Solution, Applied Biosystems, MBA, Advanced Engineering Materials, Company, Board of directors, Science, Celanese, Industrial internet of things, Security (finance), Life, Invitrogen, Life Technologies, Annual report, Terminology, Health, Efficiency, Risk, Thermo Fisher Scientific, Management, Director, Avantor

Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and industrial solutions, today announced that Mark Stevenson and Michael Stubblefield joined its Board of Directors on July 28, 2022.

Key Points: 
  • Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and industrial solutions, today announced that Mark Stevenson and Michael Stubblefield joined its Board of Directors on July 28, 2022.
  • Prior to becoming CEO of Avantor in 2014, Mr. Stubblefield served as a senior expert in the Chemicals Practice for McKinsey & Company.
  • Mr. Stubblefield earned an MBA from Texas A&M University-Corpus Christi and a bachelors degree in chemical engineering from the University of Utah.
  • Im excited to welcome Mark and Michael to our Board, said Ingersoll Rand Chairman of the Board of Directors and Chief Executive Officer Vicente Reynal.

Avantor® Names Kitty Sahin Executive Vice President, Strategy and Corporate Development

Retrieved on: 
Tuesday, July 19, 2022
Research, University, Corning, Novantae, Business, LinkedIn, Covidien, Original equipment manufacturer, Science, NYSE, Twitter, Bachelor of Arts in Organizational Psychology, Business administration, Wharton School of the University of Pennsylvania, Business development, Corporate development, EVP, Yale University, Master of Business Administration, Charles River Laboratories, Thermo Fisher Scientific, Industry, Company, Laboratory, Growth, Bain & Company, Strategy, Head, Corporation, Kitty, Fortune 500, Health, Management, Facebook, Avantor

RADNOR, Pa., July 19, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries has appointed veteran strategy and M&A executive, Kitty Sahin, to the newly created role of EVP, Strategy and Corporate Development, effective immediately. In this role, Ms. Sahin will report to President and CEO Michael Stubblefield.

Key Points: 
  • RADNOR, Pa., July 19, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries has appointed veteran strategy and M&A executive, Kitty Sahin, to the newly created role of EVP, Strategy and Corporate Development, effective immediately.
  • In her role at Avantor, Ms. Sahin will be responsible for leading the Company's strategy and corporate development team to shape and execute the enterprise growth strategy through organic and inorganic initiatives.
  • Ms. Sahin most recently served as EVP, Strategy & Business Development at Novanta, a leading supplier of proprietary technologies to medical and advanced industrial equipment OEMs.
  • Previously, she served as Head of Strategy & Business Development, Specialty Diagnostics Group and Senior Director, Corporate Development at Thermo Fisher.

Luke Denly Joins Caron as Global Director of Marketing

Retrieved on: 
Tuesday, July 12, 2022
Bachelor of Science, Club, Marketing, Multimedia, Solution, Education, Health care, UCSD, View, CEO, Gunnerus Sustainability Award, Salk Institute for Biological Studies, Sutro Biopharma, Therapy, Incubator, University of California, San Diego, Research, Growth, University, Avantor, Industry, Biology, Pharmaceutical industry, Waste management, Science, Caron, Biotechnology

MARIETTA, Ohio, July 12, 2022 /PRNewswire/ -- Caron Products and Services, Inc. ("Caron"), a leading provider of laboratory equipment used in small and large molecule drug development and manufacturing, cell and gene therapy research, and academic research, today announced Luke Denly has joined the company as Global Director of Marketing. Based in Northern [email protected]

Key Points: 
  • MARIETTA, Ohio, July 12, 2022 /PRNewswire/ -- Caron Products and Services, Inc. ("Caron"),a leading provider of laboratory equipment used in small and large molecule drug development and manufacturing, cell and gene therapy research, and academic research, today announced Luke Denly has joined the company as Global Director of Marketing.
  • Luke brings to Caron nearly 20 years of industry experience combining both research and business backgrounds.
  • Over the past ten plus years Luke was a Director at Avantor Sciences where he used his data-driven insights to provide solutions that enhanced the customer experience.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/luke-denly-joins-caron-as-globa...
    SOURCE Caron Products and Services, Inc. ("Caron")

Avantor® to Host Second Quarter 2022 Earnings Call on Friday, July 29, 2022

Retrieved on: 
Thursday, June 30, 2022
Avantor, Fortune 500, Laboratory, Science, LinkedIn, Company, Twitter, NYSE, Research, Health, Online gambling, Facebook

To participate by phone, please dial (844) 200 6205 (domestic) or (929) 526 1599 (international) and use the conference code 554992.

Key Points: 
  • To participate by phone, please dial (844) 200 6205 (domestic) or (929) 526 1599 (international) and use the conference code 554992.
  • A live webcast can be accessed on the investors section of Avantor's website and a replay will be available through August 29, 2022.
  • The earnings press release and presentation will also be posted to the Company's website.
  • Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve.

Avantor Named Best Company for Upstream Processing and Single-Use Solutions at BMK 2022

Retrieved on: 
Thursday, June 30, 2022
Science, Patient, Global health, LinkedIn, Research, Left, Laboratory, Award, Golden LEAF Biomanufacturing Training and Education Center, BMK, Biopharmaceutical, Organization, China Biologic Products, Safety, Twitter, Fine chemical, Pharmaceutical industry, Avantor, Facebook

Incheon, Korea, June 30, 2022 - (ACN Newswire) - Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, acquired awards for the best company in upstream processing and single-use solutions at the Biologics Manufacturing Korea (BMK) 2022 conference.

Key Points: 
  • Incheon, Korea, June 30, 2022 - (ACN Newswire) - Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, acquired awards for the best company in upstream processing and single-use solutions at the Biologics Manufacturing Korea (BMK) 2022 conference.
  • In single-use solutions, Avantor received the best company award for the third consecutive year.
  • Avantor was recognized for strengthening production capabilities and establishing an optimized supply chain in collaboration with global partners to respond to the growing need of biopharmaceutical manufacturers for single-use solutions.
  • Narayana Rao Rapolu, Vice President, Biopharma Asia Middle East & Africa for Avantor said, “Avantor's single-use solutions enable biomanufacturers to bring new therapies to market faster and improve global health.